Genesco Inc. secured unanimous backing from ISS, Glass Lewis, and Egan-Jones in its proxy fight with activist shareholder Bradley Radoff, a clean sweep that functionally ends the campaign eleven days before the annual meeting. The footwear retailer, trading at a $640 million market cap, now faces no meaningful resistance to its nine incumbent directors. Radoff's dissident slate—two nominees seeking board seats—lost institutional credibility the moment the third advisory opinion posted.

ISS published first, followed within 72 hours by Glass Lewis and Egan-Jones. Each firm cited Genesco's operational turnaround under CEO Mimi Vaughn, who took the helm in July 2020 and restructured the portfolio around Journeys, Schuh, and Johnston & Murphy while shedding Lids. The advisors noted Radoff's nominees lacked direct footwear or omnichannel retail experience at comparable scale. Glass Lewis specifically highlighted Genesco's $2.3 billion in trailing twelve-month revenue and year-over-year comp-store improvement, metrics Radoff's campaign materials did not address with alternative strategy.

The sweep matters because proxy advisors drive 25-30% of institutional vote outcomes at small-cap retailers. Passive index funds and mid-tier asset managers defer to ISS recommendations in over 60% of contested director elections, per Harvard Law School's shareholder rights project. When all three firms align, the dissident's path narrows to family offices and retail holders—constituencies that rarely swing 15% of float at a $640 million company. Radoff would need a populist momentum campaign or a last-minute operational miss to revive credibility. Genesco reported Q3 earnings on December 5, 2024, posting adjusted EPS of $1.52 against consensus of $1.38, which removes the latter scenario.

The broader signal is governance hygiene at mid-cap apparel plays. Genesco's board added two independent directors in 2022 and 2023, refreshed compensation structure, and published clear capital allocation priorities—all standard ISS checklist items. Radoff's campaign centered on capital return and M&A optionality but did not surface specific transactions or provide debt-adjusted return math. ISS and Glass Lewis both noted the lack of actionable alternatives in their reports. The market read this as activist theater rather than engineered value realization.

Operators should track Genesco's May 2025 annual meeting for final vote tallies and any surprise dissident support above 8-10%, which would indicate latent shareholder frustration despite advisor alignment. Watch for Radoff's next target—his firm typically cycles through three to four small-cap campaigns per year, and a loss here pressures the pipeline. Also monitor whether Genesco accelerates buybacks or announces a special dividend in the June-August 2025 window, a common post-campaign gesture to preempt future activism.

The vote is procedural now. The intelligence is in watching which activist funds quietly exit positions in the two weeks before the meeting, and whether Genesco's management uses the clean sweep to negotiate sale alternatives without public pressure.